Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
about
Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase-4 inhibitor, examined in non-obese diabetic miceTherapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once-daily injection of insulin glargine in non-obese diabetic mice.Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.Genetic evidence for involvement of neuronally expressed S1P₁ receptor in nociceptor sensitization and inflammatory pain.The immunosuppressant FTY720 (fingolimod) enhances glycosaminoglycan depletion in articular cartilage.Sphingolipid metabolites in inflammatory disease.Development of small-molecule inhibitors of sphingosine-1-phosphate signalingSphingosine-1-phosphate signaling and its role in disease.Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis.Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis.Effector T cells in rheumatoid arthritis: lessons from animal models.The role of sphingosine 1-phosphate in immunity and sepsis.Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.G protein-coupled receptors in rheumatology.Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review.Inhibitory effects of H-Ras/Raf-1-binding affibody molecules on synovial cell function.Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis.FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.Sphingosine-1-Phosphate Promotes the Persistence of Activated CD4 T Cells in Inflamed Sites.S1P receptor antagonists fingolimod and siponimod do not improve the outcome of experimental autoimmune myasthenia gravis mice after disease onset.A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.Fingolimod hydrochloride gel shows promising therapeutic effects in a mouse model of atopic dermatitis.
P2860
Q33603301-E23CCF5F-288A-47C3-9F45-FE5D3EAA7BDDQ33609788-7F15C266-D3E7-4DF0-BA23-14FFAF6095A4Q33651898-4A2505B5-562E-4889-8D87-159E0233FF4CQ33831886-DEC8CECB-982B-4D62-827E-398DC7B28D58Q34094557-402024D4-6392-40DC-BC01-73525D3750A9Q35061720-EBA90ECB-0E4F-4636-B661-8B7A2BEB33F2Q35489007-7E0E0584-C6F0-4653-8937-808D79D4332BQ35661485-ED44C2D8-629E-4B3B-9516-E4ACD6534748Q35852275-0E2EA35A-2DB9-4401-9704-25FAAD1ECAD3Q36240521-E727804B-93A1-4B7B-8246-F5C811770FC4Q37690149-95A383C9-0C1D-4381-8769-A8099ABF139BQ37813491-F92692E6-66E7-4AA0-82C2-422926A25EAEQ37868325-1CEBA579-68F5-4CFC-9246-E814A6D1C3C4Q38124035-13A09A81-7A65-40BA-A83B-6721340209A3Q38177794-FC030496-E161-4199-A49C-0E2CB4862A10Q38209549-5C9DB821-8A40-4E04-A04B-DCF7965BD942Q38618883-2E0374F4-B8B0-46C8-97F1-14D09C609342Q38844227-FD35378A-33E1-4BB7-96DF-048FAF8B10D7Q38869471-F926BBB5-1BB0-40FC-B50E-19A4A64A6383Q39021621-69F320A9-1C72-438B-91B3-2DBC16E0839DQ39398031-043E2C20-24F3-4A7B-9580-5D7D72077755Q40706687-35954060-6055-4FFE-B3FB-D4919646EDE3Q47137537-E8E02484-25A4-4328-81E8-928FAD76DC89Q47368292-DCAA5B95-83F3-43DE-A65F-B0FEF11EDC3FQ51273215-A42A2E40-96E6-43FA-A69A-1E1F58F892F1Q52857967-7B65C2E9-AE22-4C7D-848D-AD51FC184C33
P2860
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@en
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@nl
type
label
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@en
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@nl
prefLabel
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@en
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@nl
P2093
P1433
P1476
Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model.
@en
P2093
Hajime Sano
Keiji Miyazawa
Sachi Tsunemi
Sachie Kitano
Takehito Imado
Tsuyoshi Iwasaki
P304
P356
10.1016/J.CLIM.2010.03.428
P577
2010-04-24T00:00:00Z